PFKM-C351S mutation reduced the size and weight of tumors compared to those of PFKM-WT tumor, and NOS1 promotion of tumor reduced by PFKM-C351S mutation (Fig. 5a, b). This evidence concerns the gene NOS1 and neoplasm.